A new species of Acianthera (Pleurothallidinae, Orchidaceae) from Brazil

Rykaczewski, Max; Driessen, Wiel; Kolanowska, Marta

doi:10.11646/phytotaxa.372.4.6

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, as experts in orchid taxonomy [84][85][86][87], it is crucial to emphasize the fundamental role of the correct identification of plants for further studies on the usefulness of phytochemicals in cancer therapy [88][89][90]. The diversity of orchids and superficial similarity of related species often leads to erroneous identification of taxa [91,92].…”

Section: Importance Of Taxonomy and Plant Materials Preservationmentioning

confidence: 99%

Orchidaceae-Derived Anticancer Agents: A Review

Śliwiński

Kowalczyk

Sitarek

et al. 2022

Cancers

Self Cite

View full text Add to dashboard Cite

Species of orchids, which belong to the largest family of flowering plants, are commonly used in folk medicine for the treatment of infections and tumors. However, little is known about the actual chemical composition of these plants and their anticancer properties. In this paper, the most recent literature on orchid-derived bioactive substances with anticancer properties is reviewed. For the assessment, previous papers on the anticancer activity of Orchidaceae published since 2015 were considered. The papers were found by exploring electronic databases. According to the available data, many species of orchids contain potential antitumor chemicals. The bioactive substances in a relatively insignificant number of orchids are identified, and most studies are on Asian taxa. Broader research on American and African species and the correct identification of samples included in the experiments are essential for evaluating the usefulness of orchids as a plant family with vast anticancer potential.

show abstract